Claudia Cellini - Concepedia

Author

Claudia Cellini

University of Bologna ORCID

Also Known As

C Cellini, C. Cellini, Cellini, Claudia <1972>, Claudia Cellini, Federica Cavallo

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

University of Bologna Istituto Oncologico Romagnolo Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Santa Maria Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

About

Claudia Cellini is an author at University of Bologna specializing in medicine, health sciences, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.3K
2	Health Sciences	7	7	1.4K
3	Allergy	1	1	67
4	Cell Biology	1	1	25
5	Cellular Therapies	1	1	179

Claudia Cellini

Publications

Citations

H-Index

Page 1

	Year	Citations
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study Michèle Cavo, Paola Tacchetti, Francesca Patriarca, The Lancet Hematological MalignancyTransplantationMarrow TransplantationOncologyRandomised Phase 3	2010	818
Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study Michèle Cavo, Patrizia Tosi, Elena Zamagni, Journal of Clinical Oncology	2007	373
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma Michèle Cavo, Elena Zamagni, Patrizia Tosi, Blood	2005	365
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial Antonio Palumbo, Michèle Cavo, Elena Zamagni, Journal of Clinical Oncology	2011	320
The role of positron emission tomography (PET) in the management of lymphoma patients Pier Luigi Zinzani, Massimo Magagnoli, Franca Chierichetti, Annals of Oncology Positron Emission TomographyLymphoid NeoplasiaOncologic ImagingMedical ImagingPet-mri	1999	180
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. Michèle Cavo, Elena Zamagni, Patrizia Tosi, Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) First-line TherapyCell TherapyPharmacotherapyMetronomic ChemotherapyImmunotherapy	2004	179
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation Simona Soverini, Michèle Cavo, Claudia Cellini, Blood	2003	120
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure Patrizia Tosi, Elena Zamagni, Claudia Cellini, European Journal Of Haematology	2004	112
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. Patrizia Tosi, Elena Zamagni, Claudia Cellini, PubMed	2002	111
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma Patrizia Tosi, Elena Zamagni, Claudia Cellini, European Journal Of Haematology	2005	98

Page 1